Also found in: Medical.
CGRPRCalcitonin Gene-Related Peptide Receptor
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Aimovig, is the first and only FDA-approved treatment to block the calcitonin gene-related peptide receptor (CGRPR).
The most promising drugs within the pipeline include those drugs belonging to the new class of migraine medication, the CGRPR antagonists that have been shown to be an effective preventative therapy for migraines.
Immunohistochemical detection of calcitonin gene-related peptide receptor (CGRPR)-1 in the endothelium of human coronary artery and bronchial blood vessels.